APA (7th ed.) Citation

S, P., J, Y., G, T., D, R., J, B., W, Z., . . . SS, N. (2025). Clinical, tumor, and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma. The Journal of clinical investigation, 135(16), . https://doi.org/10.1172/JCI181893

Chicago Style (17th ed.) Citation

S, Poddar, et al. "Clinical, Tumor, and Product Features Associated with Outcomes After Axicabtagene Ciloleucel Therapy in Follicular Lymphoma." The Journal of Clinical Investigation 135, no. 16 (2025). https://doi.org/10.1172/JCI181893.

MLA (9th ed.) Citation

S, Poddar, et al. "Clinical, Tumor, and Product Features Associated with Outcomes After Axicabtagene Ciloleucel Therapy in Follicular Lymphoma." The Journal of Clinical Investigation, vol. 135, no. 16, 2025, https://doi.org/10.1172/JCI181893.